开盘价:-- | 最高价:-- | 最低价:-- | 52周最高价:-- | 52周最低价:-- |
成交量:-- | 平均成交量:-- | 市值:-- | 市盈率:-- | 预期市盈率:-- |
每股收益:-- | 贝塔系数:-- | 股息:-- | 收益率:-- | 总股本:-- |
证券代码:afmd | 公司名称:Affimed NV | 公司中文简称: |
公司简介: Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company鈥檚 proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany. |
||
公司网站: http://www.affimed.com |
||
公司地址: Gottlieb-Daimler-Strasse 2 Mannheim |